Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Jul;115(5):713–715. doi: 10.1111/j.1476-5381.1995.tb14991.x

Regulation of muscle glycogen metabolism by CGRP and amylin: CGRP receptors not involved.

K Beaumont 1, R A Pittner 1, C X Moore 1, D Wolfe-Lopez 1, K S Prickett 1, A A Young 1, T J Rink 1
PMCID: PMC1908511  PMID: 8548167

Abstract

The aim of the present study was to determine whether amylin and calcitonin gene-related peptide (CGRP) act through shared or distinct receptors to inhibit insulin-stimulated incorporation of [14C]-glucose into glycogen. Rat amylin was 3 fold more potent than either rat alpha CGRP or rat beta CGRP at reducing glycogen synthesis from [14C]-glucose in insulin-treated rat soleus muscle. This action was blocked by peptide antagonists, with the rank order of potency being AC187 > salmon calcitonin8-32 (sCT8-32) > h-alpha CGRP8-37 for antagonism of either amylin or CGRP. The antagonist potency order correlated with affinity for amylin receptors measured in rat nucleus accumbens but not CGRP receptors measured in rat L6 muscle cells. Inhibition of glucose incorporation into glycogen by amylin and CGRP appears to be mediated by shared receptors that have the pharmacological characteristics of amylin receptors, and are distinct from previously described CGRP receptors.

Full text

PDF
713

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beaumont K., Kenney M. A., Young A. A., Rink T. J. High affinity amylin binding sites in rat brain. Mol Pharmacol. 1993 Sep;44(3):493–497. [PubMed] [Google Scholar]
  2. Chantry A., Leighton B., Day A. J. Cross-reactivity of amylin with calcitonin-gene-related peptide binding sites in rat liver and skeletal muscle membranes. Biochem J. 1991 Jul 1;277(Pt 1):139–143. doi: 10.1042/bj2770139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Leighton B., Cooper G. J. Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature. 1988 Oct 13;335(6191):632–635. doi: 10.1038/335632a0. [DOI] [PubMed] [Google Scholar]
  4. New H. V., Mudge A. W. Calcitonin gene-related peptide regulates muscle acetylcholine receptor synthesis. 1986 Oct 30-Nov 5Nature. 323(6091):809–811. doi: 10.1038/323809a0. [DOI] [PubMed] [Google Scholar]
  5. Pittner R. A., Albrandt K., Beaumont K., Gaeta L. S., Koda J. E., Moore C. X., Rittenhouse J., Rink T. J. Molecular physiology of amylin. J Cell Biochem. 1994;55 (Suppl):19–28. doi: 10.1002/jcb.240550004. [DOI] [PubMed] [Google Scholar]
  6. Poyner D. R., Andrew D. P., Brown D., Bose C., Hanley M. R. Pharmacological characterization of a receptor for calcitonin gene-related peptide on rat, L6 myocytes. Br J Pharmacol. 1992 Feb;105(2):441–447. doi: 10.1111/j.1476-5381.1992.tb14272.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Wang M. W., Young A. A., Rink T. J., Cooper G. J. 8-37h-CGRP antagonizes actions of amylin on carbohydrate metabolism in vitro and in vivo. FEBS Lett. 1991 Oct 21;291(2):195–198. doi: 10.1016/0014-5793(91)81282-d. [DOI] [PubMed] [Google Scholar]
  8. Young A. A., Gedulin B., Gaeta L. S., Prickett K. S., Beaumont K., Larson E., Rink T. J. Selective amylin antagonist suppresses rise in plasma lactate after intravenous glucose in the rat. Evidence for a metabolic role of endogenous amylin. FEBS Lett. 1994 May 2;343(3):237–241. doi: 10.1016/0014-5793(94)80563-6. [DOI] [PubMed] [Google Scholar]
  9. Young A. A., Gedulin B., Wolfe-Lopez D., Greene H. E., Rink T. J., Cooper G. J. Amylin and insulin in rat soleus muscle: dose responses for cosecreted noncompetitive antagonists. Am J Physiol. 1992 Aug;263(2 Pt 1):E274–E281. doi: 10.1152/ajpendo.1992.263.2.E274. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES